Essex Investment Management CO LLC Athenex, Inc. Transaction History

Essex Investment Management CO LLC

  • $536 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 06, 2019
SELL
$10.24 - $15.49 $645,160 - $975,931
-63,004 Closed
0 $0
Q3 2018

Oct 16, 2018
BUY
$15.53 - $19.97 $437,604 - $562,714
28,178 Added 80.91%
63,004 $979,000
Q2 2018

Jul 17, 2018
BUY
$15.88 - $19.5 $553,036 - $679,107
34,826 New
34,826 $650,000

Others Institutions Holding ATNX

# of Institutions
3
Shares Held
1.46M
Call Options Held
0
Put Options Held
0
View Full List

About Athenex, Inc.

ATNX Quotes by TradingView
  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Essex Investment Management CO LLC Portfolio

Follow Essex Investment Management CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Essex Investment Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Essex Investment Management CO LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email